*<p>Compounds that have been previously reported to interact with ABCB1. References are listed separately (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0060334#pone.0060334.s004" target="_blank">Text S1</a>).</p><p>KB-V1 cells treated with the kinase inhibitor library of 193 compounds at 10 µM and 1 µM calcein AM were examined by the IncuCyte<sup>TM</sup>FLR. The object intensities of each sample were normalized to XR9576 treated cells and expressed as the percentage of inhibition. Compounds that displayed at least 50% inhibition of ABCB1-mediated efflux in all three independent experiments are listed.</p
Charles University Faculty of Pharmacy in Hradec Králové Department of Pharmacology & Toxicology Stu...
P-Glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) are two efflux transporters at t...
Multiple drug resistance (MDR) is characterized by the resistance of cancer cells to a broad spectru...
ABCB1, also known as P-glycoprotein (P-gp) or multidrug resistance protein 1 (MDR1), is a membrane-a...
ABCB1, also known as P-glycoprotein (P-gp) or multidrug resistance protein 1 (MDR1), is a membrane-a...
<p>Three independent experiments were performed to screen the inhibitor library in the cell imaging-...
<p><b>A.</b> KB-V1 cells were treated with BEZ235, BI 2536, IKK 16, ispinesib, and bryostatin-1 and ...
<p><b>A.</b> Time-and dose-dependent fluorescent calcein accumulation in KB-V1 cells. Various concen...
Chemotherapeutics tumor resistance is a principal reason for treatment failure, and clinical and exp...
Chemotherapeutics tumor resistance is a principal reason for treatment failure, and clinical and exp...
The prominent role for the drug efflux pump ABCB1 (P-glycoprotein) in mediating resistance to chemot...
ATP-binding cassette (ABC) transporters, which are concerned with the efflux of anticancer drugs fro...
The prominent role for the drug efflux pump ABCB1 (P-glycoprotein) in mediating resistance to chemot...
The cell membrane P-glycoprotein (P-gp; MDR1, ABCB1) is an energy-dependent efflux pump that belongs...
Although many mechanisms exist, resistance of tumors to cancer therapy drugs is the principal reason...
Charles University Faculty of Pharmacy in Hradec Králové Department of Pharmacology & Toxicology Stu...
P-Glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) are two efflux transporters at t...
Multiple drug resistance (MDR) is characterized by the resistance of cancer cells to a broad spectru...
ABCB1, also known as P-glycoprotein (P-gp) or multidrug resistance protein 1 (MDR1), is a membrane-a...
ABCB1, also known as P-glycoprotein (P-gp) or multidrug resistance protein 1 (MDR1), is a membrane-a...
<p>Three independent experiments were performed to screen the inhibitor library in the cell imaging-...
<p><b>A.</b> KB-V1 cells were treated with BEZ235, BI 2536, IKK 16, ispinesib, and bryostatin-1 and ...
<p><b>A.</b> Time-and dose-dependent fluorescent calcein accumulation in KB-V1 cells. Various concen...
Chemotherapeutics tumor resistance is a principal reason for treatment failure, and clinical and exp...
Chemotherapeutics tumor resistance is a principal reason for treatment failure, and clinical and exp...
The prominent role for the drug efflux pump ABCB1 (P-glycoprotein) in mediating resistance to chemot...
ATP-binding cassette (ABC) transporters, which are concerned with the efflux of anticancer drugs fro...
The prominent role for the drug efflux pump ABCB1 (P-glycoprotein) in mediating resistance to chemot...
The cell membrane P-glycoprotein (P-gp; MDR1, ABCB1) is an energy-dependent efflux pump that belongs...
Although many mechanisms exist, resistance of tumors to cancer therapy drugs is the principal reason...
Charles University Faculty of Pharmacy in Hradec Králové Department of Pharmacology & Toxicology Stu...
P-Glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) are two efflux transporters at t...
Multiple drug resistance (MDR) is characterized by the resistance of cancer cells to a broad spectru...